New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...

The Medicaid expansion provided health insurance coverage to millions of Americans. Learn more about the positive impact of the program and how it supports public health.

New partnerships with Tidepool Loop, plus two new models of virtual clinical care

An oral (pill) version of Ozempic, Rybelsus, becomes the first GLP-1 agonist pill for type 2 diabetes

Comedian and actor Billy Gardell spoke with diaTribe about his journey with type 2 diabetes and how he has changed both his outlook and his habits

These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments

What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019

New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health

Under the 2020 health plan, Walmart employees get an incredible network of high-quality healthcare professionals. Ask your boss if this type of investment in employee...

Powerful A1C-lowering from Victoza now an option for ages 10-17, in addition to metformin and insulin

The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...

A bipartisan legislation, which would have protected patients from surprise medical bills, is blocked from passing this year

Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...

Maria shares her experiences and strategies for managing blood sugar levels while studying abroad

Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo

As we demand more nutritious and sustainable food, big food companies must make adjustments to their products, practices, and marketing

A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease

Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020

Adam’s presentation at Friends for Life 2019

The new BioSense ketone breath meter offers unlimited, effortless ketone measurements – just blow into the device